Equities Analysts Offer Predictions for Delek US Q3 Earnings

Delek US Holdings, Inc. (NYSE:DK) – Research analysts at Zacks Research lifted their Q3 2026 earnings estimates for shares of Delek US in a research note issued to investors on Monday, September 21st. Zacks Research analyst Team now expects that the oil and gas company will post earnings per share of $2.05 for the quarter, up from their prior forecast of $1.77. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Delek US’s current full-year earnings is $15.83 per share. Zacks Research also issued estimates for Delek US’s Q4 2026 earnings at $1.70 EPS, FY2026 earnings at $9.31 EPS, Q1 2027 earnings at $0.94 EPS, Q2 2027 earnings at $1.52 EPS, Q3 2027 earnings at $1.73 EPS, Q4 2027 earnings at $1.68 EPS, FY2027 earnings at $5.88 EPS, Q1 2028 earnings at $0.14 EPS, Q2 2028 earnings at $0.02 EPS and FY2028 earnings at $0.02 EPS.

Delek US (NYSE:DK) last issued its quarterly earnings data on Wednesday, August 5th. The oil and gas company reported $5.48 earnings per share for the quarter, topping analysts’ consensus estimates of $2.67 by $2.81. Delek US had a return on equity of 109.03% and a net margin of 1.86%.The firm had revenue of $4.09 billion during the quarter, compared to analysts’ expectations of $3.44 billion. During the same period in the prior year, the business posted ($0.56) EPS. The firm’s quarterly revenue was up 47.9% on a year-over-year basis.

DK has been the topic of several other reports. Raymond James Financial upped their target price on Delek US from $72.00 to $90.00 and gave the company an “outperform” rating in a research report on Monday, September 14th. Wall Street Zen raised shares of Delek US from a “buy” rating to a “strong-buy” rating in a report on Sunday, August 9th. The Goldman Sachs Group upped their price objective on shares of Delek US from $73.00 to $83.00 and gave the stock a “buy” rating in a research report on Tuesday, August 18th. Wells Fargo & Company raised their target price on Delek US from $59.00 to $82.00 and gave the company an “overweight” rating in a research report on Tuesday, September 1st. Finally, JPMorgan Chase & Co. upped their price target on Delek US from $57.00 to $62.00 and gave the stock a “neutral” rating in a report on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $65.45.

Delek US Trading Down 1.6%

NYSE:DK opened at $73.20 on Wednesday. Delek US has a 52 week low of $25.85 and a 52 week high of $82.27. The firm has a 50 day moving average of $68.68 and a 200 day moving average of $53.52. The company has a quick ratio of 0.47, a current ratio of 0.76 and a debt-to-equity ratio of 7.53. The stock has a market capitalization of $4.48 billion, a price-to-earnings ratio of 20.56, a PEG ratio of 0.37 and a beta of 0.59.

Hedge Funds Weigh In On Delek US

Several institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in Delek US in the second quarter valued at approximately $275,233,000. Norges Bank purchased a new stake in Delek US in the 4th quarter valued at $48,374,000. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in Delek US by 1,173.2% during the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 954,900 shares of the oil and gas company’s stock worth $28,322,000 after purchasing an additional 879,900 shares during the period. Bank of America Corp DE purchased a new position in Delek US during the 2nd quarter worth $37,664,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in Delek US during the 2nd quarter worth $22,987,000. 97.01% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Delek US

In other news, EVP Mark Hobbs sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $64.59, for a total transaction of $1,291,800.00. Following the transaction, the executive vice president directly owned 104,326 shares in the company, valued at $6,738,416.34. The trade was a 16.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Sullivan, Jr. sold 27,688 shares of the stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $69.01, for a total value of $1,910,748.88. Following the completion of the sale, the director directly owned 32,004 shares of the company’s stock, valued at approximately $2,208,596.04. This represents a 46.38% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 168,377 shares of company stock valued at $11,339,985. Company insiders own 3.56% of the company’s stock.

Delek US Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 10th. Stockholders of record on Monday, August 3rd were given a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date was Monday, August 3rd. Delek US’s dividend payout ratio is 28.65%.

Key Delek US News

Here are the key news stories impacting Delek US this week:

• Positive Sentiment: Zacks Research raised several earnings forecasts and maintained a “Strong-Buy” rating. Estimates increased for Q3 2026 EPS to $2.05 from $1.77, Q4 2026 to $1.70 from $0.61, and full-year 2026 to $9.31 from $7.94. These revisions suggest analysts see improved operating conditions for Delek US’s refining business.
• Positive Sentiment: Longer-term estimates also improved materially. Zacks raised FY2027 EPS to $5.88 from $3.26, Q1 2027 to $0.94 from $0.41, Q2 2027 to $1.52 from $0.84, Q3 2027 to $1.73 from $0.93, and Q4 2027 to $1.68 from $1.08. It also moved FY2028 expectations from a $0.28 loss to $0.02 of earnings. Delek vs. HF Sinclair: Which Refining Stock Has More Upside Potential?
• Positive Sentiment: Analyst sentiment remains favorable. A separate analyst roundup assigned DK an average “Moderate Buy” rating, while recent commentary cited Delek’s strong stock performance, lower valuation, and significant EPS estimate revisions as potential upside factors. Delek US Holdings Given Average Rating of Moderate Buy by Analysts
• Neutral Sentiment: Delek US is benefiting from expectations for strong refining markets, similar to HF Sinclair. However, the stock’s outlook remains sensitive to refining margins and energy-market volatility. Delek vs. HF Sinclair: Which Refining Stock Has More Upside Potential?
• Negative Sentiment: Not all revisions were favorable. Zacks cut Q1 2028 EPS to $0.14 from $0.57, indicating weaker expectations for that period. FY2028 EPS remains only $0.02, which may temper enthusiasm about Delek’s long-term earnings trajectory.

About Delek US

Delek US Holdings, Inc (NYSE: DK) is a downstream energy company engaged primarily in petroleum refining, wholesale fuel marketing and logistics. The company produces transportation fuels and other refined petroleum products, including gasoline, diesel, jet fuel and asphalt.

Delek US operates refineries in the southern United States, including facilities in Texas, Arkansas and Louisiana. Its refining operations are supported by crude oil gathering, transportation, storage and other logistics activities conducted through Delek Logistics Partners, a publicly traded master limited partnership that is managed and partially owned by Delek US.

Founded in 2001 and headquartered in Brentwood, Tennessee, Delek US serves regional markets across the central and southeastern United States.